4-(Cyanomethyl)-2,3,5,6-tetrafluorobenzonitrile, 97%, 5g

3,5-BIS(BROMOMETHYL)PYRIDINE HYDROBROMIDE, 95.0%, 100mg

5-[4-(ethylsulfonyl)phenyl]-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

2-Chloro-4-dimethylamino-benzoic acid, 5g

(1s,3s)-3-(Benzyloxy)cyclobutanol, 95.0%, 5g

tert-Butyl 3-oxo-2,3-dihydro-1H-pyrazole-1-carboxylate, 98%, 250mg

Microliter syringe MICROLITER® series 700 Tip type 2, 250 µl, 725 N, 1 piece

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

4-Chloroquinoline-3-carboxylic acid, 95+%, 5g

n-(1-Hydroxypropan-2-yl)acetamide, 98%, 250mg

Ethyl 3-thiophen-2-yl-[1,2,4]oxadiazole-5-carboxylate, 95.0%, 1g

3-hydroxy-2-methyl-1,3-diphenylprop-2-en-1-one, 98%, 100mg

2,6-DIAZA-SPIRO[3.4]OCTAN-7-ONE TOLUENE-4-SULFONIC ACID SALT, 95.0%, 250mg